Jeff Slezak to Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
This is a "connection" page, showing publications Jeff Slezak has written about Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18.
Connection Strength
0.453
-
Human papillomavirus vaccine series completion in boys before and after recommendation for routine immunization. Vaccine. 2017 02 07; 35(6):897-902.
Score: 0.141
-
Quadrivalent Human Papillomavirus Vaccine Initiation in Boys Before and Since Routine Use: Southern California, 2009-2013. Am J Public Health. 2015 Dec; 105(12):2549-56.
Score: 0.130
-
Unmasking in an observational vaccine safety study: Using type 2 diabetes mellitus as an example. Vaccine. 2015 Nov 17; 33(46):6224-6.
Score: 0.129
-
Quadrivalent human papillomavirus vaccine uptake in adolescent boys and maternal utilization of preventive care and history of sexually transmitted infections. Am J Public Health. 2013 Sep; 103(9):e63-8.
Score: 0.028
-
Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine. J Intern Med. 2012 Feb; 271(2):193-203.
Score: 0.025